Related Experiment Video

Updated: Jul 11, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Perioperative management of multidrug-resistant organisms in health care settings

Patti G Grota

    AORN Journal
    |September 8, 2007
    PubMed

    Insights

    Healthcare Infection Control Practices Advisory Committee (HICPAC) guidelines help prevent multidrug-resistant organism (MDRO) transmission. Perioperative nurses must implement these strategies to protect surgical patients from MDRO infections.

    Area of Science:

    • Infection Control
    • Healthcare Epidemiology
    • Perioperative Nursing

    Background:

    • Multidrug-resistant organisms (MDROs) pose a significant threat in healthcare settings.
    • Preventing cross-transmission of MDROs is crucial for patient safety.
    • Existing guidelines provide a framework for managing MDROs.

    Purpose of the Study:

    • To inform perioperative nurses about HICPAC guidelines for MDRO management.
    • To emphasize the role of perioperative nurses in preventing MDRO transmission.
    • To highlight the importance of intensified interventions during MDRO outbreaks.

    Main Methods:

    • Review of Healthcare Infection Control Practices Advisory Committee (HICPAC) guidelines published in October 2006.
    • Analysis of recommended strategies for preventing MDRO cross-transmission.
    • Identification of perioperative nurses' responsibilities in implementing these strategies.

    Main Results:

    • HICPAC guidelines offer strategies to prevent MDRO cross-transmission.
    • Elevating contact precautions to "intensified interventions" is recommended for endemic outbreaks.
    • Perioperative nurses play a key role in adhering to and championing infection control practices.

    Conclusions:

    • Perioperative nurses must be prepared to implement HICPAC guidelines to protect surgical patients.
    • Active participation in infection control, leadership, and clinical support by nurses is essential.
    • Adherence to intensified interventions is critical in facilities with MDRO outbreaks.

    Related Concept Videos

    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
    Clinical Significance of Antibiotic Resistance01:25

    Clinical Significance of Antibiotic Resistance

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    Healthcare Associated Infections II: Preventive Measures01:22

    Healthcare Associated Infections II: Preventive Measures

    Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
    The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
    Development of Antibiotic Resistance01:30

    Development of Antibiotic Resistance

    Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...